KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,137,924 | -44.2% | 81,865 | -7.7% | 0.02% | -39.3% |
Q2 2023 | $2,039,949 | -23.1% | 88,732 | -0.9% | 0.03% | -36.4% |
Q1 2023 | $2,651,766 | +17.8% | 89,496 | -0.8% | 0.04% | +4.8% |
Q4 2022 | $2,251,043 | +27.3% | 90,186 | +11.1% | 0.04% | +35.5% |
Q3 2022 | $1,768,000 | -5.6% | 81,194 | -14.6% | 0.03% | -6.1% |
Q2 2022 | $1,872,000 | -61.4% | 95,073 | -17.0% | 0.03% | -26.7% |
Q1 2022 | $4,846,000 | -36.4% | 114,506 | -4.5% | 0.04% | +4.7% |
Q4 2021 | $7,616,000 | -1.6% | 119,953 | -8.9% | 0.04% | +7.5% |
Q3 2021 | $7,736,000 | +46.9% | 131,694 | +21.3% | 0.04% | +53.8% |
Q2 2021 | $5,266,000 | – | 108,578 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
AtonRa Partners | 34,462 | $750,000 | 0.74% |
Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |